Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial

dc.creatorRamalho, Dario Brock
dc.creatorSilva, Rosiana Estéfane da
dc.creatorSenna, Maria Camilo Ribeiro de
dc.creatorMoreira, Hugo Silva Assis
dc.creatorPedras, Mariana Junqueira
dc.creatorAvelar, Daniel Moreira de
dc.creatorSaraiva, Lara
dc.creatorRabello, Ana Lucia Teles
dc.creatorCota, Gláucia Fernandes
dc.date.accessioned2019-07-01T13:13:56Z
dc.date.accessioned2023-09-05T15:35:50Z
dc.date.available2019-07-01T13:13:56Z
dc.date.available2023-09-05T15:35:50Z
dc.date.created2019-07-01T13:13:56Z
dc.date.issued2018
dc.identifierRAMALHO, Dario Brock et al. Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 113, n. 9, p. 1-8, 2018.
dc.identifier0074-0276
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/33745
dc.identifier10.1590/0074-02760180200
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8668144
dc.languageeng
dc.publisherFundação Oswaldo Cruz
dc.rightsopen access
dc.titleMeglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial
dc.typeArticle


Este ítem pertenece a la siguiente institución